Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 113 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 6664247

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Dec 16, 2003 · Expires Dec 11, 2023

    expired

  2. US 6660731

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Dec 9, 2003 · Expires Dec 4, 2023

    expired

  3. US 6656746

    Antibodies to human kunitz-type inhibitor

    The Regents of the University of New Mexico · Granted Dec 2, 2003 · Expires Nov 27, 2023

    expired

  4. US 6656939

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Dec 2, 2003 · Expires Nov 27, 2023

    expired

  5. US 6653300

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Nov 25, 2003 · Expires Nov 20, 2023

    expired

  6. US 6653309

    Inhibitors of IMPDH enzyme technical field of the invention

    Vertex Pharmaceuticals Incorporated · Granted Nov 25, 2003 · Expires Nov 20, 2023

    expired

  7. US 6653301

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Nov 25, 2003 · Expires Nov 20, 2023

    expired

  8. US 6649643

    Imidazol-4-ylmehanols and their use as inhibitors of steroid C17-20 lyase

    Takeda Chemical Industries Ltd. · Granted Nov 18, 2003 · Expires Nov 13, 2023

    expired

  9. US 6649654

    Methods for identifying and using IKK inhibitors

    The Regents of the University of California · Granted Nov 18, 2003 · Expires Nov 13, 2023

    expired

  10. US 6649640

    Isoxazole compositions useful as inhibitors of ERK

    Vertex Pharmaceuticals Incorporated · Granted Nov 18, 2003 · Expires Nov 13, 2023

    expired

  11. AU 2003222814

    PHARMACEUTICAL COMPOSITION COMPRISING A LIPASE INHIBITOR AND GLUCOMANNAN

    HOFFMANN LA ROCHE [DE] · Granted Nov 10, 2003 · Expires Nov 5, 2023

    expired

  12. US 6642227

    Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Nov 4, 2003 · Expires Oct 30, 2023

    expired

  13. US 6638926

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Oct 28, 2003 · Expires Oct 23, 2023

    expired

  14. US 6638543

    Use of natural EGFR inhibitors to prevent side effects due to retinoid therapy, soaps, and other stimuli that activate the epidermal growth factor receptor

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 28, 2003 · Expires Oct 23, 2023

    expired

  15. US 6635644

    Inhibitors of p38

    Vertex Pharmaceuticals Incorporated · Granted Oct 21, 2003 · Expires Oct 16, 2023

    expired

  16. US 6632809

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Oct 14, 2003 · Expires Oct 9, 2023

    expired

  17. US 6632962

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Oct 14, 2003 · Expires Oct 9, 2023

    expired

  18. US 6632945

    Inhibitors of P38

    Vertex Pharmaceuticals Incorporated · Granted Oct 14, 2003 · Expires Oct 9, 2023

    expired

  19. US 6632808

    Inhibitors of amyloid formation

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 14, 2003 · Expires Oct 9, 2023

    expired

  20. US 6630464

    Cyclin dependent kinase (CDK)4 inhibitors and their use for treating cancer

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 7, 2003 · Expires Oct 2, 2023

    expired

  21. US 6630447

    Peptide inhibitors of LFA-1/ICAM-1 interaction

    The Regents of the University of New Mexico · Granted Oct 7, 2003 · Expires Oct 2, 2023

    expired

  22. US 6624166

    Pyridazines as interleukin-1&bgr; converting enzyme inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 23, 2003 · Expires Sep 18, 2023

    expired

  23. US 6623938

    I-flice, a novel inhibitor of tumor necrosis factor receptor-1 and CD-95 induced apoptosis

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 23, 2003 · Expires Sep 18, 2023

    expired

  24. US 6617309

    Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease

    Vertex Pharmaceuticals Incorporated · Granted Sep 9, 2003 · Expires Sep 4, 2023

    expired

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.